SCHEMBL1760153

SCHEMBL1760153

CC(C)(C)OC(=O)NCC[C@H](C=O)c1ccc(Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RECQL P46063 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
FPR3 P25089 4/20 0.42
FPR2 P25090 4/20 0.42
CTSK P43235 3/20 0.41
CTSS P25774 1/20 0.41
MALT1 Q9UDY8 1/20 0.39
AAK1 Q2M2I8 4/20 0.39
CNR1 P21554 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
KCNA5 P22460 1/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9536355 0.87 MEN1 (0.48) MEN1GAAKMT2ACTSKCTSS
SCHEMBL19331769 0.83 FPR3 (0.47) NPC1RECQLRAB9ASMN1; SMN2MEN1
SCHEMBL2726076 0.81 MEN1 (0.43) NPC1RECQLRAB9ASMN1; SMN2MEN1
SCHEMBL1141270 0.81 MEN1 (0.43) NPC1RECQLRAB9ASMN1; SMN2MEN1
SCHEMBL5808816 0.80 MEN1 (0.56) MEN1GAAKMT2ACTSKCTSS
SCHEMBL19578897 0.76 CTSS (0.41) NPC1RECQLRAB9ASMN1; SMN2MEN1
SCHEMBL17373694 0.74 AAK1 (0.47) NPC1RECQLRAB9ASMN1; SMN2FPR3
SCHEMBL5877530 0.74 AAK1 (0.50) NPC1RECQLRAB9ASMN1; SMN2FPR3
SCHEMBL255676 0.74 AAK1 (0.50) NPC1RECQLRAB9ASMN1; SMN2FPR3
SCHEMBL30257063 0.74 AAK1 (0.47) NPC1RECQLRAB9ASMN1; SMN2FPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635560-A1 DIHYDROOXAZOL-2-AMINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2013-09-11 EP disclosed
EP-2499121-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS. F. Hoffmann-La Roche AG (CH) 2012-09-19 EP disclosed
WO-2012059371-A1 DIHYDROOXAZOL-2-AMINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-05-10 WO disclosed
WO-2011057973-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2011-05-19 WO disclosed